Search Page

1

Cite

Share

Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease.

Dahl R, Greefhorst LA, Nowak D, Nonikov V, Byrne AM, Thomson MH, Till D, Della Cioppa G; Formoterol in Chronic Obstructive Pulmonary Disease I Study Group. Dahl R, et al. Among authors: thomson mh. Am J Respir Crit Care Med. 2001 Sep 1;164(5):778-84. doi: 10.1164/ajrccm.164.5.2007006. Am J Respir Crit Care Med. 2001. PMID: 11549532 Clinical Trial.

Cite

Share

2

Cite

Share

Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma.

Dahl R, Creemers JP, Van Noord J, Sips A, Della Cioppa G, Thomson M, Andriano K, Kottakis J, Fashola T. Dahl R, et al. Respiration. 2004 Mar-Apr;71(2):126-33. doi: 10.1159/000076672. Respiration. 2004. PMID: 15031566 Clinical Trial.

Cite

Share

3

Cite

Share

Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD.

Rossi A, Kristufek P, Levine BE, Thomson MH, Till D, Kottakis J, Della Cioppa G; Formoterol in Chronic Obstructive Pulmonary Disease (FICOPD) II Study Group. Rossi A, et al. Among authors: thomson mh. Chest. 2002 Apr;121(4):1058-69. doi: 10.1378/chest.121.4.1058. Chest. 2002. PMID: 11948033 Clinical Trial.

Cite

Share

4

Cite

Share

One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma.

Bensch G, Berger WE, Blokhin BM, Socolovsky AL, Thomson MH, Till MD, Castellsague J, Della Cioppa G; International Study Group on Foradil Evaluation in Pediatric Asthma. Bensch G, et al. Among authors: thomson mh. Ann Allergy Asthma Immunol. 2002 Aug;89(2):180-90. doi: 10.1016/s1081-1206(10)61935-7. Ann Allergy Asthma Immunol. 2002. PMID: 12197575 Clinical Trial.

Cite

Share

5

Cite

Share

Self-propelled particles that transport cargo through flowing blood and halt hemorrhage.

Baylis JR, Yeon JH, Thomson MH, Kazerooni A, Wang X, St John AE, Lim EB, Chien D, Lee A, Zhang JQ, Piret JM, Machan LS, Burke TF, White NJ, Kastrup CJ. Baylis JR, et al. Among authors: thomson mh. Sci Adv. 2015 Oct 2;1(9):e1500379. doi: 10.1126/sciadv.1500379. eCollection 2015 Oct. Sci Adv. 2015. PMID: 26601282 Free PMC article.

Cite

Share

6

Cite

Share

Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody.

Reilly M, Miller RM, Thomson MH, Patris V, Ryle P, McLoughlin L, Mutch P, Gilboy P, Miller C, Broekema M, Keogh B, McCormack W, van de Wetering de Rooij J. Reilly M, et al. Among authors: thomson mh. Clin Pharmacol Ther. 2013 Nov;94(5):593-600. doi: 10.1038/clpt.2013.150. Epub 2013 Jul 23. Clin Pharmacol Ther. 2013. PMID: 23880971 Free PMC article. Clinical Trial.

Cite

Share

7

Cite

Share

Ganciclovir therapy in iatrogenically immunosuppressed patients with cytomegalovirus disease.

Thomson MH, Jeffries DJ. Thomson MH, et al. J Antimicrob Chemother. 1989 Jun;23 Suppl E:61-70. doi: 10.1093/jac/23.suppl_e.61. J Antimicrob Chemother. 1989. PMID: 2550413

Cite

Share

8

Cite

Share

Efficacy and safety of two different dose levels of ganciclovir for the treatment of cytomegalovirus chorioretinitis in AIDS patients.

Gaub J, Poulsen AG, Pedersen C, Tinning S, Højgaard K, Thomson MH, Faber V, Nielsen JO. Gaub J, et al. Among authors: thomson mh. Scand J Infect Dis. 1988;20(5):479-82. doi: 10.3109/00365548809032494. Scand J Infect Dis. 1988. PMID: 2851877 Clinical Trial.

Cite

Share

9

Cite

Share

Captopril--a new treatment for severe congestive heart failure.

Kendall MJ, Smith SR, Thomson MH. Kendall MJ, et al. Among authors: thomson mh. J Clin Hosp Pharm. 1982 Dec;7(4):231-44. doi: 10.1111/j.1365-2710.1982.tb01028.x. J Clin Hosp Pharm. 1982. PMID: 6761368 No abstract available.

Cite

Share